Modulators of leukocytic functions;Les modificateurs des fonctions leucocytaires

Journal des Maladies Vasculaires

Volumn 23, Issue 2, 1998, Pages 119-124

  Nguyen, P ^a   Broussas, M ^a   Hezard N ^a   Cornillet, P ^a   Potron, G ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Atherosclerosis; Leukocyte; Monocyte; Polymorphonuclear neutrophil

Indexed keywords

1 [2 [[5 (N OCTADECYLCARBAMOYLOXYMETHYL)TETRAHYDROFURFURYLOXY]HYDROXYPHOSPHINYLOXY]ETHYL]QUINOLINIUM; 2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; ACETYLSALICYLIC ACID; ALLOPURINOL; ALPHA TOCOPHEROL; BEPAFANT; BN 22115; CYTOKINE; DIPYRIDAMOLE; FREE RADICAL; GINKGOLIDE; GINKGOLIDE B; ILOPROST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; INTERLEUKIN 1; LEUKOCYTE ELASTASE; MONOCLONAL ANTIBODY; OXYGEN RADICAL; PENTOXIFYLLINE; RP 55270; SALICYLIC ACID DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOPLASTIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTERY DISEASE; ARTICLE; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MONOCYTE; NEUTROPHIL; NONHUMAN; THROMBOCYTE; VASCULAR DISEASE;

ANIMALS; CYCLIC AMP; FREE RADICALS; HUMANS; LEUKOCYTES; MONOCYTES; NEUTROPHILS; PLATELET ACTIVATING FACTOR; VASCULAR DISEASES;

EID: 0031965685     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. BARSTADT RM, HAMERS MJAG, STEPHENS RW, SAKARIASSEN KS. Retinoic acid reduces induction of monocyte factor and tissue factor/factor Vlla-dependent arterial thrombus formation. Blood, 1995; 86: 212-8.
2. BAYNES JW, Role of oxidative stress in the development of complications in diabetes. Diabetes, 1991; 40: 405-12.
3. BRAQUET P, LAURENT JP, ROLLAND A, MARTIN C, POMMIER S, et coll. From gingkolides to N-substituted piperidinothienodiazepines, a new series of highly potent dual antagonists. In: Samuelson B, éd. Advances in prostaglandin, thromboxane, and leukotriene research. Raven Press, New York, 1990; 21: pp 937-9.
4. BROZNA JP, CARSON SD. Monocyte-associated tissue factor is suppressed by phorbol myristate acetate. Blood, 1988; 72: 456-62.
5. CHATELAIN P, LATOUR JG, TRAN D, DE LORGERIL M, DUPRAS G, BOURASSA M. Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation, 1987. 75: 1083-90.
6. CIUFFETTI G, MERCURI M, OTT C, LOMBARDINI R, PALTRICCIA R, et coll. Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study. Euro J Clin Pharmacol, 1991; 41: 511-5.
7. CRONSTEIN BN, LEVIN RI, BELANOFF J, WEISSMANN G, HIRCH-HORN R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest, 1986; 78: 760-70.
8. CRUTCHLEY DJ, CONAN LB, QUE FG. Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-a and interleukin-1β in human monocytic THP-1 cells. J Pharmacol Exp Ther, 1994; 271: 446-51.
9. CRUTCHLEY DJ, HIRS MJ. The stable prostacyclin analog. Iloprost and prostaglandin El inhibit monocyte procoagulant activity in vitro. Blood, 1991; 78: 382-6.
10. DE PROST D, OLLIVIER V, HAKIM J. Pentoxifylline inhibition of procoagulant activity generated by activated mononuclear cells. Mol Pharmacol, 1990; 38: 562-6.
11. DE PROST D, OLLIVIER V, TERNISIEN C, CHOLLET-MARTIN S. Increased monocyte procoagulant activity independent of the lupus anticoagulant in patients with systemic lupus erythematosus. Thromb Haemost, 1990; 64: 216-21.
12. DROY-LEFAIX MT, DROUET Y, GERAUD G, HOSFORD D, BRAQUET P. Superoxide dismutase (SOD) and PAF antagonist (BN 52021) reduce small intestinal damage induced by ischemia reperfusion. Free Rad Res Comms, 1991; 12: 725-35.
13. ENDRES SR, GHORBANI VE, KELLEY VE, GEORGILIS K, LONNEMANN G, et coll. The effects of dietary supplementation with n-3 fatty polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med, 1989; 320: 265-71.
14. ENGLER RL, DAHLFREN MD, MORRIS DD, PETERSON MA, SCHMIDT-SCHONBEIN GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol, 1986; 20: H314-22.
15. ENGLER RL, SCHMIDT-SCHONBEIN GW, PAVELEE RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol, 1983; 111: 98-111.
16. ERNST E, MATRAI A, PAULSEN F. Leukocyte rheology in recent stroke. Stroke, 1987; 18: 59-62.
17. FARUQI R, de LA MOTTE C, DI CORLETO PE. α-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest, 1994. 94: 592-600.
18. FRANTZ B, O'NEILL EA. The effect of sodium salicylate and aspirin on NF-kB. Science, 1995; 270: 2017-8.
19. FRIEDMAN GD, SELBY JV, QUESENBERRY JR CP. The leukocyte count: a predictor of hypertension. J Clin Epidemiol, 1990; 43: 907-11.
20. HALLIWELL B, GUTTERIDGE JMC, CROSS CE. Free radicals, antioxidants and human diseases: where are we now? Clin Lab Med, 1992; 119: 598-20.
21. JUDE B, WATEL A, FONTAINE O, FONTAINE P, COSSON A. Distinctive features of procoagulant response of monocytes from diabetic patients. Haemostasis, 1989; 19: 68-73.
22. JUDE B, AGRAOU B, MC FADDEN EP, SUSEN S, BAUTERS C, et coll. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation, 1994; 90: 1662-8.
23. KAMINSKI WE, JENDRASCHAK E, KIEFL R, VON SCHACKY C. Dietary ω3 fatty acids lower levels of platelet derived growth factor mRNA in mononuclear cells. Blood, 1993; 81: 1871-9.
24. KELLEY JL, ROZEK MM, SUENRAM CA, SCHWARTZ CJ. Activation of human peripheral blood monocytes by lipoproteins. Am J Pathol. 1988; 130: 223-31.
25. KIM JA, WAYNER E, CARLOS TM, PARHAMI F, SMITH CW, et coll. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler Thromb, 1994; 14: 427-33.
26. KOYAMA T, NISHIDA K, OHDAMA S, SAWAMA M, MURAKAMI N, et coll. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol, 1994; 87: 343-7.
27. LEE TH, HOOVER RL, WILLIAMS JD, RAVALESE J, SPUR BW, et coll. Effect of dietary enrichment with eisosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function, N Engl J Med, 1985; 312: 1217-24.
28. MACKMAN N, BRAND K, EDGINGTON TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kB binding sites. J Exp Med, 1991; 174: 1517-26.
29. MAZZONE T, JENSEN M, CHAIT A. Human arterial wall cells secrete factors that are chemotactic for monocytes. Proc Nath Acad Sci USA, 1983; 80: 5094-7.
30. NASH GB, CHRISTOPHER B, MORRIS AJR, DORMANDY JA. Changes in the flow properties of white blood cells after acute myocardial infarction. Br Heart J. 1989; 62: 329-34.
31. NASH GB, LOOSEMORE T, THOMAS PRS, DORMANDY JA. Effects of acute Trental infusion on white blood cell rheology in patients with critical leg ischaemia. Clin Haemorheol, 1991; 11: 309-15.
32. NASH GB, THOMAS PRS, DORMANDY JA. Abnormal flow properties of white blood cells in patients with severe ischemia of the leg. BMJ, 1988; 296: 1699-701.
33. NERI SERNERI GG, ABBATE R, GENSINI GF, GORI AM, ATTANASIO M, MARTINI F. Monocyte activation and increased procoagulant activity in unstable angina. Lancet, 1990; 336: 1444-5.
34. NERI SERNERI GG, ABBATE R, GORI AM, ATTANASIO M, MARTINI F et coll. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation, 1992; 86: 790-7.
35. NGUYEN P, PETITFRERE E, POTRON G. Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific P.A.F. receptor antagonists. Thromb Res, 1995; 78: 33-42.
36. OETH P, MACKMAN N. Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells. Blood, 1995; 86: 4144-52.
37. OLLIVIER V, SHEIBANI A, CHOLLET S, et coll. Monocyte procoagulant activity and membrane-associated D-Dimer after knee replacement surgery. Thromb Res, 1989; 55: 179-85.
38. OLLIVIER V, HOUSSAYE S, TERNISIEN C, LEON A, DEVERNEUIL H, et coll. Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. Blood, 1993; 81: 973-9.
39. OSNES LTN, Foss KB, JOO GB, OKKENHAUG C, WESTVIK AB, et coll. Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kB/cRel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alpha (TNF-α) in human monocytes. Thromb Haemost, 1996; 76: 970-6.
40. PIERCE JW, READ MA, DING H, LUSCINSKI FW, COLLINS T. Salicylates inhibit Ikβ-a phosphorylation, endothelial-leukocyte adhesion molecule expression and neutrophil transmigration. J Immunol, 1996; 156: 3961-9.
41. POTRON G, PETITFRERE E, NGUYEN P. Platelet activating factor and ischemia. Clin Hemor, 1993; 13: 155-76.
42. RENESTO P, KADIRI C, CHIGNARD M. Combined activation of platelets by cathepsin G and platelet activating factor, two neutrophil-derived agonists. Br J Haematol, 1992; 80: 205-13.
43. RUF W, EDGINGTON TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J, 1994; 8: 385-90.
44. SAITO T, KOYAMA T, NAGATA K, KAMIYAMA R, HIROSAWA S. Anticoagulant effects of retinoic acids on leukemia cells. Blood, 1996; 87: 657-65.
45. SCHMIDT EB, PEDERSEN JO, EKELUND S, GRUNNET N, JERSILD C, DYERBERG J. Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis, 1989; 77: 53-7.
46. SCHMID-SCHONBEIN GS. Granulocyte activation in capillary obstruction. In: Liepsch DW, ed. Blood flow in large arteries: applications to atherogenesis and clinical medicine. Basel: Karger, 1990: p 150-9.
47. SELAK M, CHIGNARD M, SMITH JB. Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J, 1988; 266: 55-62.
48. SHAH V, WALLIN JD, EILEEN SD. Chemioluminescence and superoxide anion production by leukocytes from diabetic patients. J Clin Endocrinol Metabolism, 1983; 57: 402-9.
49. TREMOLI E, ELIGINI S, COLLI S, MADERNA P, RISE P, et coll. N-3 fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes. Arteriosclcr Thromb, 1994; 14: 1600-8.
50. WALSER A, FLYNN T, MASON C, CROWLEY H, MARESCA C, et coll. Triazolobenzo and triazolothienodiazepines as potent antagonists of platelet-activating factor. J Med Chem, 1991; 34: 1209-21.
51. WEBER C, ERL W, PIETSCH A, WEBER PC. Aspirin inhibits nuclear factor-kB mobilisation and monocyte adhesion in stimulated human endothelial cells. Circulation, 1995; 91: 1914-7.
52. WILCOX JN, SMITH KM, SCHWARTZ SM, GORDON D. Localization of tissue factor in normal vessel wall in the atherosclerotic plaque. Proc Nath Acad Sci USA, 1989; 86: 2839-43.